Man Group’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-12,654
Closed -$34.8K 1896
2024
Q3
$34.8K Sell
12,654
-53,045
-81% -$146K ﹤0.01% 1787
2024
Q2
$148K Buy
+65,699
New +$148K ﹤0.01% 1785